Albert Bourla

Shares of Pharmacy-benefit managers (PBMs) including CVS Health Corp (NYSE:CVS), UnitedHealth Group Inc (NYSE:UNH) and Cigna Group (NYSE:CI) are moving lower Tuesday on continued downside pressure following aggressive commentary from President-elect Donald Trump ...

Pfizer Inc. (NYSE:PFE) CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the pharmaceutical giant’s struggling share price and refine its strategic focus. The meeting comes as Starboard builds a $1 billion stake in Pfizer, equivalent...

The CEOs of major companies, including Palantir Technologies Inc. (NYSE:PLTR), Oracle Corp. (NYSE:ORCL), and Pfizer Inc. (NYSE:PFE), lobbied U.S. senators for support of Israel during its Gaza invasion and to find a solution for the hostages held by Hamas. What Happened: Palantir’s Alexander...

Nvidia Corp.'s (NASDAQ:NVDA) CEO Jensen Huang is rumored to be visiting China on Tuesday for the first time in four years. Incidentally, a slew of corporate head honchos have been heading to the country. What Happened: China has held out a lot of promise for U.S. companies, given its status as a...

Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr. Anthony Fauci, who in his previous capacity as the director of the National Institute of Allergy And Infectious Diseases, spearheaded the vaccine drive against the pandemic. It came as a surprise that...

Seagen Inc (NASDAQ: SGEN) shares are trading higher Monday after Pfizer Inc (NYSE: PFE) announced plans to acquire the global biotech company. What Happened: Seagen and Pfizer entered into a definitive merger agreement under which Pfizer will acquire Seagen ...

Pfizer Inc (NYSE: PFE) applied for emergency use authorization of its oral antiviral Paxlovid last week after reporting data showing that it was 89% effective at preventing hospitalization or death in at-risk people. Pfizer CEO Albert Bourla is confident that the oral antiviral will not...

Pfizer Inc (NYSE: PFE) is trading higher after the company announced its COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of a Phase 2/3 study. Pfizer said it will cease further enrollment into the study due to the overwhelming...

Pfizer Inc (NYSE: PFE) is trading higher Tuesday after the company announced better-than-expected third-quarter financial results and raised guidance. Pfizer reported quarterly earnings of $1.34 per share, which beat the estimate of $1.09 per share. The company reported quarterly revenue of $24.1...

Shares of cruise line stocks including Carnival Corp (NYSE: CCL) and Royal Caribbean Group (NYSE: RCL) are trading higher Monday amid reopening optimism as investors weigh vaccine progress and booster shot developments. Pfizer Inc (NYSE: PFE) CEO Albert Bourla said he sees a return to normal within...

Pfizer Inc (NYSE: PFE) CEO Albert Bourla said that there is a likelihood that annual booster shots of the coronavirus vaccine will be needed. What Happened: Bourla said in an interview with ABC’s “This Week” program that the COVID-19 vaccine could morph into an annual shot. ...

Pfizer Inc. (NYSE: PFE) CEO said the company is working on a specialized vaccine targeting the highly contagious delta variant of COVID-19. What Happened: “We are making a specialized vaccine for Delta. I am almost certain that we will not need it because the booster shot of the current...

Real-world data coming out of Israel shows that Pfizer Inc. (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) COVID-19 vaccine is more than 90% effective in preventing asymptomatic infections, and the world now has a "message of hope," Pfizer CEO Albert Bourla said Thursday on CNBC's...

Pfizer Inc. (NYSE: PFE) CEO Albert Bourla sold more than $5.5 million of his company's stock at nearly the same time the company announced an encouraging COVID-19 vaccine update. While the sale doesn't appear to be illegal, the Securities and Exchange Commission likely has a set of...